Pay in 4 interest-free payments of $7.05 Learn more
Ships within 48 hours · Estimated delivery Nov 5 - Nov 10
Some of this work reached early human investigation: full-length Thymosin Beta-4 has been examined in clinical-stage research for indications such as dry-eye disease and wound healing, which gives TB-500's parent compound a somewhat broader human-research footprint than BPC-157 although the synthetic TB-500 fragment itself remains a research compound without approval
Its stability in gastric and systemic environments makes it a valuable compound for ongoing laboratory research into regenerative mechanisms and cytoprotective processes
My Clinical Perspective DSIP exemplifies the complexity of evaluating peptides
Your healthcare provider can create a plan that's right for you
(2) F M Ng, W J Jiang, R Gianello, S Pitt, and P Roupas (2000)
US$ 20.06
US$ 27.39
US$ 25.91
US$ 20.79
US$ 20.08
